(Q39679553)

13 September 2017

title

Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease (English)

1 reference

13 September 2017

1 reference

Chao Li

1

1 reference

13 September 2017

Yuan Guo

2

1 reference

13 September 2017

Wenjie Xie

3

1 reference

13 September 2017

Xingang Li

4

1 reference

13 September 2017

Joseph Janokovic

5

1 reference

13 September 2017

Weidong Le

6

1 reference

13 September 2017

publication date

16 July 2010

1 reference

13 September 2017

published in

Neurochemical Research

1 reference

13 September 2017

volume

35

1 reference

13 September 2017

issue

10

1 reference

13 September 2017

page(s)

1546-1556

1 reference

https://scigraph.springernature.com/pub.10.1007/s11064-010-0214-3

13 September 2017

exact match

0 references

cites work

Clinical strategies to prevent and delay motor complications

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11064-010-0214-3

An update on the treatment of Parkinson's disease.

21 January 2018

1 reference

12 December 2020

Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies.

1 reference

12 December 2020

Dopamine agonist monotherapy in Parkinson's disease

1 reference

12 December 2020

A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease

1 reference

12 December 2020

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

12 December 2020

The mTOR pathway as a potential target for the development of therapies against neurological disease

1 reference

12 December 2020

Dopamine D3 receptor agonists for protection and repair in Parkinson's disease

1 reference

12 December 2020

Pathological proteins in Parkinson's disease: focus on the proteasome

1 reference

12 December 2020

Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators

1 reference

12 December 2020

Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease

1 reference

12 December 2020

Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice

1 reference

12 December 2020

Molecular pathophysiology of Parkinson's disease

1 reference

12 December 2020

Are dopamine receptor agonists neuroprotective in Parkinson's disease?

1 reference

12 December 2020

Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement

1 reference

12 December 2020

Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease

1 reference

12 December 2020

Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration

1 reference

12 December 2020

Modeling Parkinson's disease

1 reference

12 December 2020

Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole

1 reference

12 December 2020

Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons

1 reference

12 December 2020

Autophagy and neurodegeneration: when the cleaning crew goes on strike

1 reference

12 December 2020

Etiopathogenesis of Parkinson disease: a new beginning?

1 reference

12 December 2020

Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation.

1 reference

12 December 2020

Stereology, morphometry, and mapping: the whole is greater than the sum of its parts

1 reference

12 December 2020

Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion.

1 reference

12 December 2020

Loss of autophagy in the central nervous system causes neurodegeneration in mice

1 reference

12 December 2020

The rotenone model of parkinsonism--the five years inspection.

1 reference

12 December 2020

Autophagy as a regulated pathway of cellular degradation

1 reference

12 December 2020

Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group

1 reference

12 December 2020

10.1007/S11064-010-0214-3

Identifiers

DOI

1 reference

13 September 2017

1 reference